Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07411729Recruiting

Establishment of a Biobank for the Evaluation of Rapid Diagnostic Solutions

Role: collaborator

NCT07253311Not Yet Recruiting

Evaluation of Rapid Diagnostic Device for the Detection of Candida Auris

Role: collaborator

NCT06840197Not Yet Recruiting

DiagRaMIE Mpox Virus-RDC for the Diagnostic of Monkeypox

Role: collaborator

NCT05378217Completed

AMR-DetecTool for the Diagnostic of MDR Bacterial Infections

Role: collaborator

All 4 trials loaded